Line 149: | Line 149: | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <a href="https://www.sparkasse-bielefeld.de/de/home.html" target="_blank"><img class="figure | + | <a href="https://www.sparkasse-bielefeld.de/de/home.html" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/7c/T--Bielefeld-CeBiTec--ES--Partners--Sparkasse-Bielefeld.jpeg"></a> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Two_Third"> | <div class="column_Two_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <a href="https://www.jowat.com/en/" target="_blank"><img class="figure | + | <a href="https://www.jowat.com/en/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/72/T--Bielefeld-CeBiTec--ES--Partners--Jowat.png"></a> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure | + | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/b/be/T--Bielefeld-CeBiTec--ES--Partners--QIAGEN.jpeg"> |
</figure> | </figure> | ||
Line 168: | Line 168: | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <a href="http://www.weissbiotech.com/" target="_blank"><img class="figure | + | <a href="http://www.weissbiotech.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/5/55/T--Bielefeld-CeBiTec--ES--Partners--WeissBioTech.gif"></a> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Two_Third"> | <div class="column_Two_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <a href="https://www.symrise.com/" target="_blank"><img class="figure | + | <a href="https://www.symrise.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/0/02/T--Bielefeld-CeBiTec--ES--Partners--symrise.jpeg"></a> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure | + | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/6d/T--Bielefeld-CeBiTec--ES--Partners--CYANAGEN.jpeg"> |
</figure> | </figure> | ||
</div> | </div> | ||
</div> | </div> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure | + | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/c/cb/T--Bielefeld-CeBiTec--ES--Partners--ZYMO-RESEARCH.jpeg"> |
</figure> | </figure> | ||
<br></br><br></br> | <br></br><br></br> | ||
Line 198: | Line 198: | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <a href="https://www.cebitec.uni-bielefeld.de/" target="_blank"><img class="figure | + | <a href="https://www.cebitec.uni-bielefeld.de/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/69/T--Bielefeld-CeBiTec--ES--Partners--CeBiTec.png"></a> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Two_Third"> | <div class="column_Two_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure | + | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/a/ab/T--Bielefeld-CeBiTec--ES--Partners--Carl-Roth.png"> |
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure | + | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/2/2e/T--Bielefeld-CeBiTec--ES--Partners--Zierold-Stiftung.jpeg"> |
</figure> | </figure> | ||
</div> | </div> |
Revision as of 13:27, 17 October 2018
Sponsors and partners